Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B
    1.
    发明授权
    Compositions comprising coagulation factors IXA and VIII for the treatment of haemophilia A or B 失效
    包含用于治疗血友病A或B的凝血因子IXA和VIII的组合物

    公开(公告)号:US07977460B2

    公开(公告)日:2011-07-12

    申请号:US10829042

    申请日:2004-04-21

    IPC分类号: A61K38/39

    摘要: The present invention relates to the use of FIXa and FVIII in the preparation of a composition for the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies. The present invention further relates to a composition comprising FIXa and a composition comprising FVIII for simultaneous, simultaneous separate or sequential use in the treatment of haemophilia A or haemophilia B in a subject which does not present with anti-FVIII antibodies.

    摘要翻译: 本发明涉及FIXa和FVIII在制备用于治疗不存在抗FVIII抗体的受试者中的血友病A或血友病B组合物的用途。 本发明还涉及包含FIXa的组合物和包含FVIII的组合物,用于在不存在抗FVIII抗体的受试者中同时,同时分开或顺序地用于治疗血友病A或血友病B。